Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin in Advanced Adrenocortical Carcinoma
NCT00002921Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 1997
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of suramin in adrenocortical carcinoma (ACC), sponsored by SWOG Cancer Research Network. Primary endpoint: Response to suramin. Started Mar 1997; status: terminated.
02
Drugs
suramin
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT00002921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002921.